TNFRSF11B and ovarian cancer: Similar studies, but in a different biological material, were conducted by Chudecka-Głaz et al. [38], who evaluated the concentration of selected cytokines, proteins, and growth, including osteoprotegerin in the peritoneal fluid of patients with ovarian cancer or benign gynaecological conditions.